{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:51:52Z","timestamp":1792266712041,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajpath.2023.10.008","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:43:59Z","timestamp":1699026239000},"page":"165-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-024X","authenticated-orcid":false,"given":"Jonathan","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-7042","authenticated-orcid":false,"given":"Vida","family":"Ehyaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-3221","authenticated-orcid":false,"given":"Vanessa","family":"Perez-Silos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-8469","authenticated-orcid":false,"given":"Alejandro","family":"Zevallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Maienschein-Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Brister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-865X","authenticated-orcid":false,"given":"Maria","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshana","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-2704","authenticated-orcid":false,"given":"Jayalakshmi","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Symes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-7323","authenticated-orcid":false,"given":"John K.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-2900","authenticated-orcid":false,"given":"Peter H.","family":"Gann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lopez-Hisijos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2410","authenticated-orcid":false,"given":"John","family":"Reneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-2608","authenticated-orcid":false,"given":"Girish","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-680X","authenticated-orcid":false,"given":"Nathanael","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar","family":"Inamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-5066","authenticated-orcid":false,"given":"Carlos","family":"Murga-Zamalloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2023.10.008_bib1","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.2014.60.4363","article-title":"Long-term course of patients with stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"33","author":"Eichenauer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib2","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3324\/haematol.2015.133025","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study","volume":"100","author":"Lazarovici","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.ajpath.2023.10.008_bib4","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood-2013-12-541078","article-title":"Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis","volume":"123","author":"Xing","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib5","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","article-title":"Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution","volume":"127","author":"Kenderian","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood-2017-02-766121","article-title":"Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma","volume":"130","author":"Fanale","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","article-title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"133","author":"Borchmann","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3109\/10428194.2014.961013","article-title":"A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma","volume":"56","author":"Shet","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ajpath.2023.10.008_bib9","doi-asserted-by":"crossref","first-page":"72197","DOI":"10.18632\/oncotarget.12363","article-title":"A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma","volume":"7","author":"Schuhmacher","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2023.10.008_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib11","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/cancers13123021","article-title":"Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics","volume":"13","author":"Younes","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2023.10.008_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41379-022-01016-8","article-title":"3D analyses reveal T cells with activated nuclear features in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"35","author":"Sadeghi Shoreh Deli","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00428-011-1165-z","article-title":"T cell\/histiocyte-rich large B-cell lymphoma: an update on its biology and classification","volume":"459","author":"Tousseyn","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2023.10.008_bib14","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib15","first-page":"300","article-title":"Nodular lymphocyte-predominant hodgkin lymphoma or T-cell\/histiocyte rich large B-cell lymphoma: the problem in \u201cgrey\u00a0zone\u201d lymphomas","volume":"1","author":"Zhao","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2013.02.010","article-title":"Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland","volume":"44","author":"Nathwani","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fonc.2015.00132","article-title":"Spatial separation of Plk1 phosphorylation and activity","volume":"5","author":"Bruinsma","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib18","doi-asserted-by":"crossref","first-page":"114474","DOI":"10.18632\/oncotarget.22967","article-title":"Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas","volume":"8","author":"Murga-Zamalloa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2023.10.008_bib19","article-title":"How to obtain the P value from a confidence interval","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajpath.2023.10.008_bib20","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.celrep.2017.10.085","article-title":"SUMOylation promotes nuclear import and stabilization of polo-like kinase 1 to support its mitotic function","volume":"21","author":"Wen","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2023.10.008_bib21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41467-017-01876-8","article-title":"Coupling of polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry","volume":"8","author":"Kachaner","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2023.10.008_bib22","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/bloodadvances.2019000232","article-title":"The role of aurora A and polo-like kinases in high-risk lymphomas","volume":"3","author":"Murga-Zamalloa","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajpath.2023.10.008_bib23","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.humpath.2009.03.025","article-title":"Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival","volume":"40","author":"Muenst","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib25","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib26","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1007\/s00262-021-02945-0","article-title":"Immune infiltrate diversity confers a good prognosis in follicular lymphoma","volume":"70","author":"Tsakiroglou","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajpath.2023.10.008_bib27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2741\/s114","article-title":"CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignancies","volume":"2","author":"Kelley","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.ajpath.2023.10.008_bib28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/ijms17122127","article-title":"Characterization of the microenvironment of nodular lymphocyte predominant Hodgkin lymphoma","volume":"17","author":"Visser","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2023.10.008_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2023.10.008_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2023.10.008_bib31","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00428-013-1519-9","article-title":"The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone","volume":"464","author":"Rajnai","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2023.10.008_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2023.10.008_bib34","first-page":"361","article-title":"Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course","volume":"3","author":"Lippman","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fimmu.2013.00455","article-title":"Inhibitory receptor expression depends more dominantly on differentiation and activation than \u201cexhaustion\u201d of human CD8 T cells","volume":"4","author":"Legat","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.998538","article-title":"Consensus nomenclature for CD8(+) T cell phenotypes in cancer","volume":"4","author":"Apetoh","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ajpath.2023.10.008_bib37","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2023.10.008_bib38","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.4049\/jimmunol.0900848","article-title":"Cutting edge: tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells","volume":"183","author":"Shafer-Weaver","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib39","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1158\/0008-5472.CAN-08-4516","article-title":"Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells","volume":"69","author":"Shafer-Weaver","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2023.10.008_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2021.12.030","article-title":"TCR-induced FOXP3 expression by CD8(+) T cells impairs their anti-tumor activity","volume":"528","author":"Lozano","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2023.10.008_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708874","article-title":"CD8(+) regulatory T cell - a mystery to be revealed","volume":"12","author":"Mishra","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ijc.25693","article-title":"CD8(+) Foxp3(+) tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response","volume":"129","author":"Le","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2023.10.008_bib43","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.89.14.6550","article-title":"A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells","volume":"89","author":"Noelle","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2023.10.008_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib45","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.4049\/jimmunol.160.4.1850","article-title":"Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response","volume":"160","author":"Kaplan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2023.10.008_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","article-title":"T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells","volume":"173","author":"Chtanova","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib48","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","article-title":"Unique gene expression program of human germinal center T helper cells","volume":"104","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2023.10.008_bib49","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib50","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib51","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/342929a0","article-title":"Mechanism of antigen-driven selection in germinal centres","volume":"342","author":"Liu","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2023.10.008_bib52","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.7537388","article-title":"Generation of memory B cells and plasma cells in\u00a0vitro","volume":"268","author":"Arpin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2023.10.008_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.1","article-title":"PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival","volume":"5","author":"Yang","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ajpath.2023.10.008_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13000-018-0750-8","article-title":"PD1(hi) cells associate with clusters of proliferating B-cells in marginal zone lymphoma","volume":"13","author":"Wickenden","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrc1430","article-title":"Nuclear structure in cancer cells","volume":"4","author":"Zink","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2023.10.008_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ajpath.2023.10.008_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.13310","article-title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma","volume":"169","author":"Hartmann","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078812","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?","volume":"8","author":"Hartmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2023.10.008_bib59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41379-019-0428-0","article-title":"Diagnostic utility of STAT6(YE361) expression in classical Hodgkin lymphoma and related entities","volume":"33","author":"Van Slambrouck","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2022.08.017","article-title":"FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma","volume":"31","author":"Conde","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajpath.2023.10.008_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2023.10.008_bib62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023004157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023004157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:44:46Z","timestamp":1757695486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944023004157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0002944023004157"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.10.008","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}